ERIC KRINSKY: Open Payments
NPI 1659773612 · LOVELAND, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,723 in 114 payments from 19 companies in 2025. Trend: 2023 $2,541 · 2024 $2,829 · 2025 $2,723
Food & beverage: $2,619Education: $104
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $527 |
| Galderma Laboratories, L.P. | 10 | $420 |
| ABBVIE INC. | 20 | $342 |
| Regeneron Healthcare Solutions, Inc. | 8 | $232 |
| PFIZER INC. | 16 | $198 |
| UCB, Inc. | 6 | $198 |
| Incyte Corporation | 4 | $162 |
| Janssen Biotech, Inc. | 5 | $99 |
| E.R. Squibb & Sons, L.L.C. | 4 | $96 |
| GENZYME CORPORATION | 4 | $91 |
Products named: NEMLUVIO, DUPIXENT, SKYRIZI, COSENTYX, Rhapsido, Bimzelx, CIBINQO, OPZELURA.
Industry payments across CO — which companies pay providers there.
